Combination Chemotherapy Pre-Allogeneic SCT
Pilot Study of FLAG-Ida Followed Immediately by Reduced-Intensity Allogeneic HCT for Adults Age 60 and Older With Newly Diagnosed Adverse-Risk AML or Other High-Grade Myeloid Neoplasm
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 2
- Enrollment
- 20 patients (estimated)
- Sponsors
- Fred Hutchinson / University of Washington Cancer Consortium
- Tags
- Allogeneic Stem Cell Transplant, Chemotherapy, Radiation Therapy
- Trial Type
- Treatment
- Last Update
- 2 weeks ago
- SparkCures ID
- 2138
- NCT Identifier
- NCT07046078
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.